BEUDAMED
    26 results · 51ms · Sources: EU EUDAMED, US FDA
    Filters FDA Pre Market Approval ×

    Transvenous Temporary Phrenic Nerve Stimulator

    FDA Pre-Market Approval
    FDA Class 3 ·AeroPace® System

    Transvenous Temporary Phrenic Nerve Stimulator

    FDA Pre-Market Approval
    FDA Class 3 ·AeroPace® System

    Implantable Pulse Generator, Pacemaker (Non-Crt)

    FDA Pre-Market Approval
    FDA Class 3 ·DROMOS S.L. PACING SYSTEM

    Stimulator, Low Electric Field, Tumor Treatment

    FDA Pre-Market Approval
    FDA Class 3 ·NOVOTTF-100A SYSTEM

    Dressing, Wound, Drug

    FDA Pre-Market Approval
    FDA Unclassified ·BIOBRANE(R) II

    Dressing, Wound, Drug

    FDA Pre-Market Approval
    FDA Unclassified ·BIOBRANE (R) II BLUE LABEL PRODUCT

    Dressing, Wound, Drug

    FDA Pre-Market Approval
    FDA Unclassified ·BIOBRANE

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·Heparin_Induced Extracorporeal LDL Precipitation (H.E.L.P.) Futura Apheresis System

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·PLASMAT SECURA HEPARIN-INDUCED EXTRACORPOREAL LDL APHERESIS SYSTEM (H.E.L.P.)

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·HEPARIN-INDUCED EXTRACORPOREAL LDL PRECIPITATION (H.E.L.P.)FUTURA APHERESIS SYSTEM

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·Heparin-Induced Extracorporeal LDL Precipitation (H.E.L.P.) Futura Apheresis System

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·HEPARIN-INDUCED EXTRACORPOREAL LDL PRECIPITATION (H.E.L.P.) FUTURA APHERESIS SYSTEM

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·Heparin-Induced Extracorporeal LDL Precipitation (H.E.L.P.) Futura Apheresis System

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·HEPARIN-INDUCED EXTRACORPOREAL LDL-PRECIPITATION (H.E.L.P.) FUTURA APHERESIS SYSTEM

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·PLASMAT SECURA HEPARIN-INDUCED EXTRACORPOREAL LDL APHERESIS SYSTEM (H.E.L.P.)

    Lipoprotein, Low Density, Removal

    FDA Pre-Market Approval
    FDA Class 3 ·HEPARIN-INDUCED EXTRACORPOREAL LDL PRECIPITATION (H.E.L.P.) FUTURA APHERESIS SYSTEM

    Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·Optune Lua

    Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4

    FDA Pre-Market Approval
    FDA Class 3 ·MAGE-A4 IHC 1F9 pharmDx

    Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4

    FDA Pre-Market Approval
    FDA Class 3 ·MAGE-A4 IHC 1F9 pharmDx

    Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4

    FDA Pre-Market Approval
    FDA Class 3 ·MAGE-A4 IHC 1F9 pharmDx